GL1X · GenesisL1 explorer

Research workbench

MLL1 set N3861I/Q3867L bound to inhibitor 18 (tc-5153)

Analyse MLL1 set N3861I/Q3867L bound to inhibitor 18 (tc-5153) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U9K
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase
EC
2.1.1.43
UniProt
B4DIJ7
Ligands
Q2V, ZN
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 20% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase (EC 2.1.1.43)protein14919% helix, 35% strandB4DIJ7
BHistone-lysine N-methyltransferase (EC 2.1.1.43)protein14920% helix, 35% strandB4DIJ7

Ligands and binding sites

  • Q2V · 5'-([(3S)-3-amino-3-carboxypropyl]{[1-(3,3-diphenylpropyl)azetidin-3-yl]methyl}amino)-5'-deoxyadenosine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12130.690.8634GOL
23260.580.7640Q2V
32250.480.7428Q2V

Interfaces

1 interface between chains.

  • A–B · 587 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6U9K · MLL1 SET N3861I/Q3867L bound to inhibitor 18 (TC-5153) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.